Extracellular vesicles as antigen carriers for novel vaccination avenues
Mehanny M, Lehr CM, Fuhrmann G (2021)
Publication Type: Journal article, Review article
Publication year: 2021
Journal
Book Volume: 173
Pages Range: 164-180
DOI: 10.1016/j.addr.2021.03.016
Abstract
Antigen delivery has always been a challenge in scientific practice of vaccine formulation. Yet, mammalian extracellular vesicles (EVs) or bacterial membrane vesicles (MVs) provide an innovative avenue for safe and effective delivery of antigenic material. They include intrinsically loaded antigens from EV-secreting cells or extrinsically loaded antigens onto pre-formed vesicles. Interestingly, many studies shed light on potential novel anti-cancer vaccination immunotherapy for therapeutic applications from mammalian cell host-derived EVs, as well as conventional vaccination for prophylactic applications using bacterial cell-derived MVs against infectious diseases. Here, we discuss the rationale, status quo and potential for both vaccine applications using EVs.
Authors with CRIS profile
Involved external institutions
Germany (DE)How to cite
APA:
Mehanny, M., Lehr, C.M., & Fuhrmann, G. (2021). Extracellular vesicles as antigen carriers for novel vaccination avenues. Advanced Drug Delivery Reviews, 173, 164-180. https://dx.doi.org/10.1016/j.addr.2021.03.016
MLA:
Mehanny, Mina, Claus Michael Lehr, and Gregor Fuhrmann. "Extracellular vesicles as antigen carriers for novel vaccination avenues." Advanced Drug Delivery Reviews 173 (2021): 164-180.
BibTeX: Download